Search Tag: Hologic

IMAGING Management

Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell to Kick Off Breast Cancer Awareness Month

2017 30 Sep

Trailblazing Company Behind the Genius™ 3D Mammography™ Exam Celebrates Year of Innovations in Breast Health Hologic, Inc. has announced that Steve MacMillan, the Company's Chairman, President and Chief Executive Officer, will join selected employees to ring the Nasdaq Opening Bell on October 2 in conjunction with the start of Breast Cancer... Read more

IMAGING Management

Hologic receives FDA 510(k) clearance to market SculpSure® for non-invasive body contouring

2017 30 Sep

Patients in Clinical Studies Report 100% Satisfaction Rate   Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded FDA 510(k) clearance for Cynosure's non-invasive body contouring product,  SculpSure ®. The state-of-the-art body contouring laser treatment is now cleared to treat a double chin (also... Read more

IMAGING Management

Hologic introduces a more comfortable mammogram

2017 27 Sep

93% of Women Surveyed Reported Improved Comfort with the New System* Hologic, Inc . has announced the commercial availability of its new SmartCurve™ breast stabilization system, which has been clinically proven to deliver a more comfortable mammogram without compromising image quality, workflow or dose. 1  The SmartCurve system is available... Read more

IMAGING Management

Hologic’s 3Dimensions™ Mammography System now available in Europe

2017 12 Sep

Fastest, Highest Resolution Breast Tomosynthesis System is Designed to Increase Clinical Confidence, Accuracy and Patient Comfort Hologic, Inc . has announced that the 3Dimensions ™  mammography system, the fastest, highest resolution breast tomosynthesis system ever, is available for purchase in Europe. [1]  The new product is the latest... Read more

IMAGING Management

Hologic Announces Availability of New Brevera® Breast Biopsy System

2017 31 Aug

Transformational Workflow Solution Offers Real-Time Imaging of Tissue Samples, Resulting in Major Cost and Time Savings Hologic, Inc. has announced U.S. commercial availability of the Brevera® breast biopsy system with CorLumina®imaging technology, a groundbreaking real-time breast biopsy and verification system that enhances workflow, improves... Read more

IMAGING Management

Hologic Announces Financial Results for Third Quarter of Fiscal 2017

2017 03 Aug

-- Company Posts Revenue of $806.1 Million, GAAP Diluted EPS of $0.21, and Non-GAAP Diluted EPS of $0.50 -- -- Organic Revenue Growth Led by Molecular Diagnostics and International Businesses -- Hologic, Inc. has announced the Company's financial results for the fiscal third quarter ended  July 1, 2017 .   GAAP diluted earnings per share (EPS)... Read more

IMAGING Management

Hologic to Webcast Presentations at Upcoming Investor Conferences

2017 31 Jul

 Hologic, Inc. has announced that the Company will present at these upcoming investor conferences: The Canaccord Genuity Growth Conference in  Boston, MA  on  Wednesday, August 9  at  4 p.m. Eastern Time  (ET). Morgan Stanley's 15th Annual Global Healthcare Conference in  New York, NY  on  Monday, September 11  at  9:55 a.m. ET . Each pr Read more

IMAGING Management

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2017 on Wed, August 2, 2017

2017 12 Jul

Hologic, Inc. has announced that the Company plans to release its financial results for the third quarter of fiscal 2017 on Wednesday, August 2, 2017, after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing 877-780-3379... Read more

IMAGING Management

Hologic Notified Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert

2017 03 Jul

Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2042 (CUSIP No. 436440 AC5) issued March 5, 2012, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes.   This conversion right is subject to the terms of... Read more

IMAGING Management

Hologic's New Panther Fusion® System, Flu and Respiratory Assays Now CE Marked in Europe

2017 29 Jun

New Panther Fusion® Module Expands Molecular Testing Capabilities, Increases Productivity and Flexibility for the Laboratory Hologic, Inc. has obtained a CE mark in Europe for its new Panther Fusion system and Panther Fusion assays for flu and respiratory testing, the Company has announced. The Fusion module system offers laboratories the ability... Read more